Benjamin J. C. Quah

Benjamin J. C. Quah

Auto-generated profile, based on publicly available information

Benjamin J. C. Quah

Department of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2007 in Nature Protocols
Verified
Journal Article
Closed access
BQBen J C Quah
Ben J C Quah
HWHilary S Warren
Hilary S Warren
CPChristopher Parish
Christopher Parish

1 May 2012 in Journal of Immunological Methods
Verified
Journal Article
Closed access
BQBenjamin J.C. Quah
Benjamin J.C. Quah
CPChristopher Parish
Christopher Parish

1 September 2005 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
BQBen J.C. Quah
Ben J.C. Quah
HOHelen C. O'NEill
Helen C. O'NEill

1 February 2009 in Current Protocols in Immunology
Verified
Journal Article
Open access
PDF file
CPChristopher Parish
Christopher Parish
MGMegan H. Glidden
Megan H. Glidden
BQBen J. C. Quah
Ben J. C. Quah
HWHilary S. Warren
Hilary S. Warren
The stable incorporation of the intracellular fluorescent dye 5‐(and ‐6)‐carboxyfluorescein diacetate succinimidyl ester (CFSE) into cells provides a powerful tool to monitor cell migration, and to quantify cell division, because of the sequential decrease in fluorescent labeling in daughter cells. CFSE‐labeled lymphocytes have been used to analyze the relationship between cell division and differentiation of cell function, and cell proliferation versus apoptosis, both in vivo and in vitro, and have allowed analysis of the site of response to antigens in vivo.Curr. Protoc. Immunol. 84:4.9.1‐4.9.13. © 2009 by John Wiley & Sons, Inc.

1 July 2005 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
BQBen J.C. Quah
Ben J.C. Quah
HOHelen C. O'Neill
Helen C. O'Neill
The capacity of antigen presenting dendritic cells (DC) to function in both tolerance and immunity is now well documented. The function and characteristics of different DC subsets are reviewed here and their capacity to activate T cells under different conditions of maturation and activation is discussed. The immunogenic potential of exosomes produced by DC is also considered in light of evidence that the capacity of exosomes to activate T cells for tolerance or immunity appears to mirror that of the parent DC. A model is proposed whereby exosomes produced by immature DC can function to maintain peripheral tolerance, while exosomes produced by more mature DC can stimulate effector T cells.

1 July 2004 in Stem Cells
Verified
Journal Article
Closed access
PDF file
HOHelen C. O'Neill
Helen C. O'Neill
HWHeather L. Wilson
Heather L. Wilson
BQBen Quah
Ben Quah
JAJanice L. Abbey
Janice L. Abbey
GDGeneviève Despars
Geneviève Despars
KNKeping Ni
Keping Ni
The cellular microenvironments in which dendritic cells (DCs) develop are not known. DCs are commonly expanded from CD34+ bone marrow precursors or blood monocytes using a cocktail of growth factors including GM-CSF. However, cytokine-supported cultures are not suitable for studying the intermediate stages of DC development, since progenitors are quickly driven to become mature DCs that undergo limited proliferation and survive for only a short period of time. This lab has developed a long-term culture (LTC) system from spleen which readily generates a high yield of DCs. Hematopoietic cells develop under more normal physiological conditions than in cultures supplemented with cytokines. A spleen stromal cell monolayer supports stem cell maintenance, renewal, and the specific differentiation of only DCs and no other hematopoietic cells. Cultures maintain continuous production of a small population of small-sized progenitors and a large population of fully developed DCs. Cell-cell interaction between stromal cells and progenitor cells is critical for DC differentiation. The progenitors maintained in LTC appear to be quite distinct from bone marrow-derived DC progenitors that respond to GM-CSF. The majority of cells produced in LTC are large-sized cells with a phenotype reflecting myeloid-like DC precursors or immature DCs. These cells are highly endocytotic and weakly immunostimulatory for T cells. This model system predicts in situ production of DCs in spleen from endogenous progenitors, as well as a central role for spleen in DC hematopoiesis.